{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:00:25Z","timestamp":1754154025837,"version":"3.41.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,23]]},"DOI":"10.7759\/cureus.88622","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T22:53:29Z","timestamp":1753311209000},"source":"Crossref","is-referenced-by-count":0,"title":["Rapid-Onset Heparin-Induced Thrombocytopenia Leading to Cardiogenic Shock Due to Left Anterior Descending Artery Embolism During Transcatheter Aortic Valve Replacement"],"prefix":"10.7759","author":[{"given":"Atsuhiro","family":"Kitaura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroatsu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urara","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyuki","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker A","year":"2018","unstructured":"Cuker A, Arepally GM, Chong BH, et al.. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018, 2:3360-92. 10.1182\/bloodadvances.2018024489","journal-title":"Blood Adv"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin TE","year":"1995","unstructured":"Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995, 332:1330-5. 10.1056\/NEJM199505183322003","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2109","article-title":"The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital","volume":"131","author":"Smythe MA","year":"2007","unstructured":"Smythe MA, Koerber JM, Mattson JC. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. Chest. 2007, 131:1644-9. 10.1378\/chest.06-2109","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1656329","article-title":"Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia","volume":"68","author":"Amiral J","year":"1992","unstructured":"Amiral J, Bridey F, Dreyfus M, et al.. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 1992, 68:95-6. 10.1055\/s-0038-1656329","journal-title":"Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30046-2","article-title":"Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study","volume":"5","author":"Dhakal B","year":"2018","unstructured":"Dhakal B, Kreuziger LB, Rein L, et al.. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study. Lancet Haematol. 2018, 5:e220-31. 10.1016\/S2352-3026(18)30046-2","journal-title":"Lancet Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher A","year":"2017","unstructured":"Greinacher A, Selleng K, Warkentin TE. Autoimmune heparin-induced thrombocytopenia. J Thromb Haemost. 2017, 15:2099-114. 10.1111\/jth.13813","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin TE","year":"2001","unstructured":"Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001, 344:1286-92. 10.1056\/NEJM200104263441704","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04334.x","article-title":"Heparin-induced thrombocytopenia: pathogenesis and management","volume":"121","author":"Warkentin TE","year":"2003","unstructured":"Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003, 121:535-55. 10.1046\/j.1365-2141.2003.04334.x","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2016.10.001","article-title":"Cardio-anesthesiology considerations for the trans-catheter aortic valve implantation (TAVI) procedure","volume":"57","author":"Melidi E","year":"2016","unstructured":"Melidi E, Latsios G, Toutouzas K, et al.. Cardio-anesthesiology considerations for the trans-catheter aortic valve implantation (TAVI) procedure. Hellenic J Cardiol. 2016, 57:401-6. 10.1016\/j.hjc.2016.10.001","journal-title":"Hellenic J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-23-00996","article-title":"Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry","volume":"20","author":"Yamamoto M","year":"2024","unstructured":"Yamamoto M, Yashima F, Shirai S, et al.. Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry. EuroIntervention. 2024, 20:579-90. 10.4244\/EIJ-D-23-00996","journal-title":"EuroIntervention"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-06-0523","article-title":"Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia. A systematic review and meta-analysis","volume":"115","author":"Sun L","year":"2016","unstructured":"Sun L, Gimotty PA, Lakshmanan S, Cuker A. Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia. A systematic review and meta-analysis. Thromb Haemost. 2016, 115:1044-55. 10.1160\/TH15-06-0523","journal-title":"Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13692","article-title":"Diagnostic accuracy of IgG-specific versus polyspecific enzyme-linked immunoassays in heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"15","author":"Husseinzadeh HD","year":"2017","unstructured":"Husseinzadeh HD, Gimotty PA, Pishko AM, Buckley M, Warkentin TE, Cuker A. Diagnostic accuracy of IgG-specific versus polyspecific enzyme-linked immunoassays in heparin-induced thrombocytopenia: a systematic review and meta-analysis. J Thromb Haemost. 2017, 15:1203-12. 10.1111\/jth.13692","journal-title":"J Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-661215","article-title":"Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"127","author":"Nagler M","year":"2016","unstructured":"Nagler M, Bachmann LM, ten Cate H, ten Cate-Hoek A. Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2016, 127:546-57. 10.1182\/blood-2015-07-661215","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.219.1.r01ap0695","article-title":"Early prediction of irreversible brain damage after ischemic stroke at CT","volume":"219","author":"von Kummer R","year":"2001","unstructured":"von Kummer R, Bourquain H, Bastianello S, Bozzao L, Manelfe C, Meier D, Hacke W. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology. 2001, 219:95-100. 10.1148\/radiology.219.1.r01ap0695","journal-title":"Radiology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"23","author":"Goyal M","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH, et al.. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016, 23:1723-31. 10.1016\/S0140-6736(16)00163-X","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43895-0","article-title":"A retrospective comparative study of anesthesia with remimazolam and remifentanil versus dexmedetomidine and remifentanil for transcatheter aortic valve replacement","volume":"13","author":"Kitaura A","year":"2023","unstructured":"Kitaura A, Tsukimoto S, Sakamoto H, Hamasaki S, Nakao S, Nakajima Y. A retrospective comparative study of anesthesia with remimazolam and remifentanil versus dexmedetomidine and remifentanil for transcatheter aortic valve replacement. Sci Rep. 2023, 13:17074. 10.1038\/s41598-023-43895-0","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.690875","article-title":"Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent","volume":"12","author":"Kilpatrick GJ","year":"2021","unstructured":"Kilpatrick GJ. Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent. Front Pharmacol. 2021, 12:690875. 10.3389\/fphar.2021.690875","journal-title":"Front Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77131","article-title":"Early detection of cerebral embolism during transcatheter aortic valve replacement facilitated by rapid awakening through the antagonism of remimazolam with flumazenil: a case report","volume":"17","author":"Kitaura A","year":"2025","unstructured":"Kitaura A, Yoshino Y, Sakamoto H, Tsukimoto S, Nakajima Y. Early detection of cerebral embolism during transcatheter aortic valve replacement facilitated by rapid awakening through the antagonism of remimazolam with flumazenil: a case report. Cureus. 2025, 17:e77131. 10.7759\/cureus.77131","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382146-rapid-onset-heparin-induced-thrombocytopenia-leading-to-cardiogenic-shock-due-to-left-anterior-descending-artery-embolism-during-transcatheter-aortic-valve-replacement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T22:53:29Z","timestamp":1753311209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382146-rapid-onset-heparin-induced-thrombocytopenia-leading-to-cardiogenic-shock-due-to-left-anterior-descending-artery-embolism-during-transcatheter-aortic-valve-replacement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.88622","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}